AIP
DNTH icon

Ameritas Investment Partners’s Dianthus Therapeutics DNTH Stock Holding History

Ameritas Investment Partners’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Buy
2,934
+948
+48% +$54.9K 0.01% 1144
2025
Q4 		$81.8K Buy
1,986
+613
+45% +$23.8K ﹤0.01% 1819
2025
Q3 		$54K Sell
1,373
-969
-41% -$24.8K ﹤0.01% 2067
2025
Q2 		$43.6K Hold
2,342
– – ﹤0.01% 2271
2025
Q1 		$42.5K Hold
2,342
– – ﹤0.01% 2202
2024
Q4 		$51.1K Hold
2,342
– – ﹤0.01% 2167
2024
Q3 		$64.1K Hold
2,342
– – ﹤0.01% 2048
2024
Q2 		$60.6K Buy
+2,342
New +$56.3K ﹤0.01% 2035
2022
Q2 		– Sell
-107
Closed -$5K – 3109
2022
Q1 		$5K Hold
107
– – ﹤0.01% 2962
2021
Q4 		$8K Hold
107
– – ﹤0.01% 2953
2021
Q3 		$13K Hold
107
– – ﹤0.01% 2868
2021
Q2 		$17K Hold
107
– – ﹤0.01% 2810
2021
Q1 		$20K Hold
107
– – ﹤0.01% 2556
2020
Q4 		$13K Hold
107
– – ﹤0.01% 2675
2020
Q3 		$12K Hold
107
– – ﹤0.01% 2628
2020
Q2 		$13K Hold
107
– – ﹤0.01% 2571
2020
Q1 		$11K Buy
107
+33
+45% +$6.12K ﹤0.01% 2489
2019
Q4 		$18K Hold
74
– – ﹤0.01% 2458
2019
Q3 		$12K Hold
74
– – ﹤0.01% 2651
2019
Q2 		$18K Hold
74
– – ﹤0.01% 2503
2019
Q1 		$20K Buy
74
+53
+252% +$9.14K ﹤0.01% 2372
2018
Q4 		$2K Hold
21
– – ﹤0.01% 2947
2018
Q3 		$4K Buy
+21
New +$4.42K ﹤0.01% 2964

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ameritas Investment Partners's DNTH Position: Q1 2026 in Review

Ameritas Investment Partners increased its Dianthus Therapeutics (DNTH) stake by 48% in Q1 2026, buying an estimated $54.9K and bringing the position to 2,934 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #1144.

Ameritas Investment Partners first reported a position in DNTH in Q3 2018 and has held it in 23 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Ameritas Investment Partners held 2,934 shares of Dianthus Therapeutics worth $246K as of Q1 2026.
  • Ameritas Investment Partners bought 948 Dianthus Therapeutics shares in Q1 2026, an estimated $54.9K.
  • Dianthus Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1144 holding.
  • Ameritas Investment Partners first reported a position in Dianthus Therapeutics in Q3 2018 and has held it in 23 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.